Literature DB >> 10369461

Heterogeneity of prejunctional NPY receptor-mediated inhibition of cardiac neurotransmission.

A P Serone1, C E Wright, J A Angus.   

Abstract

Neuropeptide Y (NPY) has been proposed as the candidate inhibitory peptide mediating interactions between sympathetic and vagal neurotransmission in several species, including man. Here, we have defined the NPY receptors involved in modulation of cardiac autonomic neurotransmission using receptor-selective agonists and antagonists in the rabbit and guinea-pig isolated right atria. In isolated atrial preparations, sympathetically-mediated tachycardia (ST; with atropine 1 microM) or vagally-mediated bradycardia (VB; with propranolol 0.1-1 microM) in response to electrical field stimulation (EFS, 1-4 pulses) were tested 0-30 min after incubation with single concentrations of vehicle, NPY (0.01-10 microM), the Y2 receptor agonist N-Acetyl-[Leu28,31]NPY(24-36) (termed N-A[L]NPY(24-36)) or the Y1 receptor agonist [Leu31,Pro34]NPY (LP). The effect of NPY on the concentration-chronotropic response curves to isoprenaline and bethanechol were also assessed. Guinea-pig atria: NPY and N-A[L]NPY(24-36) caused concentration-dependent inhibition of VB and ST to EFS. Both peptides caused maximal inhibition of VB and ST within 10 min incubation and this remained constant. LP caused a concentration-dependent, transient inhibition of ST which was antagonized by the Y1-receptor antagonist GR231118 (0.3 microM), with apparent competitive kinetics. Rabbit atria: NPY (1 or 10 microM) had no effect on VB at any time point, but both NPY and LP caused a transient (approximately 10 min) inhibition of sympathetic tachycardia. This inhibition could be prevented by 0.3 microM GR231118. N-A[L]NPY(24-36) had no effect on ST. NPY had no effect on the response to beta-adrenoceptor stimulation by isoprenaline nor muscarinic-receptor stimulation by bethanechol in either species. Thus, in the guinea-pig, NPY causes a stable inhibition of both VB and ST to EFS via Y2 receptors and transient inhibition of ST via Y1 receptors. In contrast in the rabbit, NPY has no effect on the cardiac vagus and prejunctional inhibition of ST is transient and mediated by a Y1-like receptor (rather than Y2). Therefore it would be surprising if NPY plays a functional role in modulation of cardiac neurotransmission in the rabbit.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369461      PMCID: PMC1565997          DOI: 10.1038/sj.bjp.0702519

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Exogenous NPY modulation of cardiac autonomic reflexes and its pressor effect in the conscious rabbit.

Authors:  A P Serone; J A Angus; C E Wright
Journal:  Br J Pharmacol       Date:  1998-04       Impact factor: 8.739

2.  Prolonged non-adrenergic inhibition of cardiac vagal action following sympathetic stimulation: neuromodulation by neuropeptide Y?

Authors:  E K Potter
Journal:  Neurosci Lett       Date:  1985-03-15       Impact factor: 3.046

3.  Frequency- and reserpine-dependent chemical coding of sympathetic transmission: differential release of noradrenaline and neuropeptide Y from pig spleen.

Authors:  J M Lundberg; A Rudehill; A Sollevi; E Theodorsson-Norheim; B Hamberger
Journal:  Neurosci Lett       Date:  1986-01-02       Impact factor: 3.046

4.  Neuropeptide Y as a putative modulator of the vagal effects on heart rate.

Authors:  M R Warner; M N Levy
Journal:  Circ Res       Date:  1989-05       Impact factor: 17.367

5.  Distribution and colocalization of neuropeptide Y- and tyrosine hydroxylase-like immunoreactivity in the guinea-pig heart.

Authors:  C Sternini; N Brecha
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

6.  Effects of neuropeptide Y (NPY) on mechanical activity and neurotransmission in the heart, vas deferens and urinary bladder of the guinea-pig.

Authors:  J M Lundberg; X Y Hua; A Franco-Cereceda
Journal:  Acta Physiol Scand       Date:  1984-08

7.  Neuropeptide Y (NPY) depresses the secretion of 3H-noradrenaline and the contractile response evoked by field stimulation, in rat vas deferens.

Authors:  J M Lundberg; L Stjarne
Journal:  Acta Physiol Scand       Date:  1984-03

8.  Neuropeptide tyrosine (NPY)--a major cardiac neuropeptide.

Authors:  J Gu; J M Polak; T E Adrian; J M Allen; K Tatemoto; S R Bloom
Journal:  Lancet       Date:  1983-05-07       Impact factor: 79.321

9.  Presynaptic inhibition of cardiac vagal postganglionic nerves by neuropeptide Y.

Authors:  E Potter
Journal:  Neurosci Lett       Date:  1987-12-16       Impact factor: 3.046

10.  Studies on cardiac distribution and function of neuropeptide Y.

Authors:  J M Allen; P Gjörstrup; J A Björkman; L Ek; T Abrahamsson; S R Bloom
Journal:  Acta Physiol Scand       Date:  1986-03
View more
  1 in total

1.  Neuropeptide Y is a prejunctional inhibitor of vagal but not sympathetic inotropic responses in guinea-pig isolated left atria.

Authors:  A P Serone; J A Angus
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.